Baker Tilly confirms auditor change effective Sept 2026
Baker Tilly US, LLP, the former independent auditor of Benitec Biopharma Inc., issued a statement confirming the disclosure of its separation as the company's certifying accountant and agreeing with the September 24, 2026, Form 8-K filing details.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed